Gallacher Capital Management’s Sony SONY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Sell
18,503
-4,180
-18% -$88.1K 0.21% 168
2026
Q1
$470K Buy
22,683
+1,056
+5% +$23.7K 0.18% 163
2025
Q4
$554K Buy
21,627
+1
+0% +$28 0.21% 139
2025
Q3
$623K Buy
21,626
+1,698
+9% +$45.7K 0.25% 131
2025
Q2
$519K Sell
19,928
-120
-0.6% -$3K 0.24% 117
2025
Q1
$509K Buy
20,048
+267
+1% +$6.17K 0.25% 104
2024
Q4
$419K Buy
19,781
+306
+2% +$5.96K 0.21% 128
2024
Q3
$376K Buy
19,475
+445
+2% +$8.11K 0.17% 155
2024
Q2
$323K Buy
19,030
+2,660
+16% +$44K 0.17% 170
2024
Q1
$281K Buy
16,370
+410
+3% +$7.54K 0.14% 197
2023
Q4
$302K Sell
15,960
-115
-0.7% -$2K 0.17% 163
2023
Q3
$265K Buy
16,075
+605
+4% +$10.6K 0.17% 171
2023
Q2
$279K Sell
15,470
-3,025
-16% -$56.7K 0.16% 185
2023
Q1
$335K Buy
18,495
+610
+3% +$10.6K 0.2% 138
2022
Q4
$273K Buy
+17,885
New +$267K 0.17% 155

Other funds holding SONY

Gallacher Capital Management's SONY Position: Q2 2026 in Review

Gallacher Capital Management reduced its Sony (SONY) stake by 18% in Q2 2026, selling an estimated $88.1K and leaving 18,503 shares worth $371K. The position accounts for 0.21% of the portfolio, ranked #168.

Gallacher Capital Management first reported a position in SONY in Q4 2022 and has held it in 15 quarters since. The position peaked at $623K in Q3 2025. 159 funds tracked by Wall St. Rank hold SONY as of Q2 2026.

  • Gallacher Capital Management held 18,503 shares of Sony worth $371K as of Q2 2026.
  • Gallacher Capital Management sold 4,180 Sony shares in Q2 2026, an estimated $88.1K.
  • Sony made up 0.21% of Gallacher Capital Management's portfolio in Q2 2026, its #168 holding.
  • Gallacher Capital Management first reported a position in Sony in Q4 2022 and has held it in 15 quarters since.
  • Gallacher Capital Management's Sony position peaked at $623K in Q3 2025.
  • 159 funds tracked by Wall St. Rank held Sony as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.